Systems and methods for using braided implants

By designing braided implants that are adapted to different blood vessel diameters, the problem of existing vascular stents is solved in the treatment of intracranial aneurysms, achieving higher therapeutic flexibility and safety.

CN110801257BActive Publication Date: 2024-11-19DEPUY SYNTHES PROD INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201910721222.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-08-06
Filing Date
2019-08-06
Publication Date
2024-11-19
Estimated Expiration
2039-08-06

AI Technical Summary

Technical Problem

Existing vascular stents are difficult to adapt to different blood vessel diameters when treating intracranial aneurysms, and traditional delivery methods are not flexible enough to tiny blood vessels, which increases the risk and complexity of the surgery.

Method used

A braided implant was designed to adapt blood vessels in the range of 1 mm to 5.5 mm vessel diameters through tapering blood vessel structure and characteristic porosity curves, providing substantially consistent porosity and pore density, reducing trauma to blood vessels and improving treatment flexibility.

Benefits of technology

A consistent porosity is achieved over a wider range of vessel diameters, reducing the number of devices required for treatment, improving the flexibility and safety of treatment, suitable for different sizes of blood vessels, and reducing the risk of surgery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN110801257B_ABST
    Figure CN110801257B_ABST
Patent Text Reader

Abstract

This disclosure relates to a braided implant configured as a flow deflector for treating aneurysms. The implant may include a braided mesh configured to maintain a substantially consistent target porosity over a predetermined length within a vessel diameter of up to 1 mm in a constricted vessel.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to implants within body vessels and, more particularly, to flow diverters, stents, and related methods including braided implants formed from strands of material. Background Art

[0002] Vascular diseases and defects such as aneurysms and other arteriovenous malformations are particularly difficult to treat when they are located near critical tissue or when the site of the malformation is not readily accessible. Both challenges are particularly true for intracranial aneurysms. Surgery to treat defects in the intracranial vasculature is extremely challenging and often dangerous because of the sensitive brain tissue surrounding intracranial blood vessels and limited access.

[0003] Typically, a delivery catheter is first used to guide the stent-like revascularization device beneath the aneurysm to be treated. One commercially available revascularization product is the CERENOVOUS Vascular reconstruction devices and systems, including CERENOVOUS The stent device is carried by a central delivery wire and initially held in place on the delivery wire in a collapsed state by a sheath-type introducer. Typically, stents such as those commercially available from Cerenovous and disclosed by Gore et al. in U.S. Pat. No. 5,662,622 The delivery catheter of the Plus microcatheter, for example, is first positioned within the blood vessel with its distal tip slightly beyond the neck of the aneurysm. The tapered distal tip of the introducer is tightly matched with the proximal hub of the delivery catheter, and then the delivery wire is advanced through the delivery catheter.

[0004] CERENOVOUS The stent device has a highly flexible, self-expanding closed-cell design with multiple coils of radiopaque wire acting as markers at each flared end of the device. These markers are relatively time-consuming and expensive to manufacture due to the small size of the stent and the need to wrap the radiopaque wire multiple times around the struts on the stent, which is particularly difficult within the closed cells of the stent.

[0005] Vascular aneurysms have a variety of treatments available. One approach includes a flow diverting stent, which may be an intravascular stent that is dense enough to divert blood flow into the aneurysm. Such flow diverters are a recent and growing treatment option. Otherwise, the majority of the current generation of flow diverters consists of a tubular braid of metal wires that operate similar to a finger catch toy. These tubular braids are then radially compressed, delivered to the treatment site through a small bore catheter, and then expanded in place.

[0006] In addition, the weakness and nonlinear nature of the neurovascular system limits the applicability of such stents in surgery, such as in repairing neurovascular defects. In addition, known delivery methods are less useful in vascular occlusion surgery, especially when it is necessary to treat tiny blood vessels such as those present in the brain. Therefore, there is a need for a braided implant used with a delivery technique in the treatment of vascular occlusion of neurovascular defects, which provides selective reinforcement near the neurovascular defect. There is also a need for a braided stent that reduces trauma to the blood vessel or reduces the risk of blood vessel rupture. The solution disclosed herein solves these and other problems in the art. Summary of the invention

[0007] Disclosed herein are various exemplary devices, systems, and methods of the present disclosure that may address the above-mentioned needs.

[0008] One object of the present solution is to provide one or more braided implants configured as flow diverters that provide a longer vessel diameter range (eg, 1 mm vessel diameter range) for tapered vessels while maintaining a target porosity within a predetermined length.

[0009] One purpose of the present solution is to increase the range of applicable vessel diameters for braided implants to minimize the number of devices required by a practitioner to treat an aneurysm. In one example, one or more braided implants include a wide plateau region of a characteristic porosity curve, thereby indicating the braided implant(s) for vessel diameters within the plateau (resulting in a 1.0 mm wide indicated range), and overlapping the range of device indications so that the physician can select the best option based on the anatomy presented.

[0010] In certain examples, a braided implant configured as a flow diverter for treating an aneurysm is disclosed. The implant may include a braided mesh configured to maintain a substantially consistent target porosity in a tapered vessel over a range of at least 1 mm vessel diameter. The braided mesh may also be configured to maintain a substantially consistent target porosity in a tapered vessel simultaneously between a proximal end and a distal end of the braided mesh.

[0011] In some examples, the tapered vessel includes a proximal diameter and a distal diameter that differ by at most 1 mm, wherein a vessel diameter range of at most 1 mm is defined by comparing the proximal diameter to the distal diameter. However, it is contemplated that the diameters may differ by at least 0.5 mm or any other diameter difference as desired or required.

[0012] In some examples, the substantially uniform target porosity is approximately 70%.

[0013] In some examples, the predetermined length between the proximal and distal ends of the braided mesh in the tapered blood vessel is at least 3 cm.

[0014] In some examples, the predetermined length between the proximal and distal ends of the braided mesh in the tapered blood vessel is at least 2 cm.

[0015] In some examples, the predetermined length between the proximal and distal ends of the braided mesh in the tapered blood vessel is at least 1 cm.

[0016] In some examples, the predetermined length between the proximal and distal ends of the braided mesh in the tapered vessel is defined between the proximal tubular internal carotid artery and the internal carotid artery terminal end.

[0017] In certain examples, a braided implant for medical use is disclosed. The implant may include a mesh having a proximal end and a distal end, wherein the mesh includes a substantially uniform porosity between the proximal end and the distal end within a radial range of 1 mm in a blood vessel diameter.

[0018] In some examples, the porosity is approximately 70% within a 1 mm radial range of the vessel diameter.

[0019] In some examples, the braided implant also includes an indicated vessel diameter, and wherein the braided implant is configured such that the indicated vessel diameter coincides with a peak of a porosity curve of the braided implant. The braided implant may include a porosity plateau corresponding to a 1 mm radial range in vessel diameter disposed about a peak of the porosity curve.

[0020] In some examples, the porosity of the braided implant is between 65% and 70% within a vessel diameter range of 2 mm to 3 mm.

[0021] In some examples, the porosity of the braided implant is between 65% and 70% over a vessel diameter range of 2.5 mm to 3.5 mm.

[0022] In some examples, the porosity of the braided implant is between 65% and 70% over a vessel diameter range of 3.0 mm to 4.0 mm.

[0023] In some examples, the porosity of the braided implant is between 65% and 70% over a vessel diameter range of 3.5 mm to 4.5 mm.

[0024] In some examples, the entire braided implant is constructed to have a vessel diameter range of 3.5 mm to 4.5 mm, and wherein the braided implant comprises a porosity of 69% at a vessel diameter of 3.5 mm; a porosity of 69% at a vessel diameter of 4.0 mm; and a porosity of 67% at a vessel diameter of 4.5 mm.

[0025] In some examples, the porosity of the braided implant is between 65% and 70% over a vessel diameter range of 4.5 mm to 5.5 mm.

[0026] In some examples, the pore density of the braided implant is 18 pores / mm 2 .

[0027] In some examples, the pore density of the braided implant is 23 pores / mm 2 .

[0028] In some examples, the pore density of the braided implant is 19 pores / mm 2 .

[0029] In some examples, the pore density of the braided implant is about 18 pores / mm 2 Up to 23 holes / mm 2 .

[0030] In some instances, the target vessel treated by the braided implant is tapered.

[0031] In some instances, the braided implant is a substantially cylindrical porous structure.

[0032] In some instances, the braided implant is a stent.

[0033] In some examples, the braided implant is a flow diverter.

[0034] In some examples, a braided implant is formed from a plurality of individual strands composed of at least a first material and one or more radiopaque strands.

[0035] In some examples, braided implant 10 is braided to include at least a second plurality of strands.

[0036] In some examples, the braided implant is formed from a plurality of strands formed from a monofilament, each of the plurality of strands being laid separately with the monofilament.

[0037] In some instances, the braided implant further comprises a woven pattern, wherein the pattern comprises openings defined by a plurality of strands oriented in a first direction and a plurality of strands oriented in a second direction transverse to the first direction.

[0038] In some examples, the braided implant further includes a braided pattern, wherein the pattern includes openings defined by a plurality of strands oriented in a first direction and a plurality of strands oriented in a second direction transverse to the first direction.

[0039] In some examples, a system for treating an aneurysm is disclosed. The system may include a plurality of braided implants, wherein each braided implant includes a substantially uniform porosity within a different 1 mm radial range of a vessel diameter, and each braided implant is configured to provide a substantially uniform porosity within a different 1 mm radial diameter range.

[0040] In some examples, the braided implant is configured for use in a tapered vessel. The tapered vessel may include a proximal diameter and a distal diameter that differ by up to 1 mm. The different 1 mm radial ranges in vessel diameter can be determined by comparing the proximal diameter and the distal diameter. However, the different 1 mm radial ranges in vessel diameter can also be determined by measuring the vessel diameter at two separate locations at the treatment site.

[0041] In some examples, the plurality of braided implants of the system are configured to treat any vessel within a diameter range of 2 mm to 3 mm.

[0042] In some examples, the plurality of braided implants of the system include a first braided implant (10) configured to treat a vessel diameter range of 2 mm to 3 mm; a second braided implant (10) configured to treat a vessel diameter range of 2.5 mm to 3.5 mm; a third braided implant (10) configured to treat a vessel diameter range of 3.0 mm to 4.0 mm; a fourth braided implant (10) configured to treat a vessel diameter range of 3.5 mm to 4.5 mm; a fifth braided implant (10) configured to treat a vessel diameter range of 4.0 mm to 5.0 mm; and a sixth braided implant (10) configured to treat a vessel diameter range of 4.5 mm to 5.0 mm. The porosity of each braided implant (10) may be in a range between 65% and 70% within the designated vessel range of the corresponding implant. In some examples, the porosity of each braided implant is approximately 70%. In some examples, each braided implant further includes an indicated vessel diameter, and wherein the braided implant is configured such that the indicated vessel diameter coincides with a peak of a porosity curve for the braided implant. In some examples, each braided implant further includes a porosity plateau corresponding to a 1 mm range of vessel diameters disposed about a peak of the porosity curve. In some examples, each braided implant includes at least about 18 pores / mm. 2 Up to 23 holes / mm 2 range of pore density.

[0043] In some examples, the pore density of the first braided implant is 18 pores / mm 2 .

[0044] In some examples, the pore density of the second braided implant is 23 pores / mm 2 .

[0045] In some examples, the pore density of the third braided implant is 18 pores / mm 2 .

[0046] In some examples, the pore density of the fourth braided implant is 19 pores / mm 2 .

[0047] In some examples, the pore density of the fifth braided implant is 23 pores / mm 2 .

[0048] In some examples, the pore density of the sixth braided implant is 21 pores / mm 2 In some examples, the braided implant includes a radiopaque material such as platinum, chromium, cobalt, tantalum, tungsten, gold, silver, and alloys thereof.

[0049] In some examples, a system for treating an aneurysm is disclosed. The system may include a plurality of braided implants, wherein each braided implant includes a substantially uniform porosity within a different 0.5 mm radial range of a vessel diameter, and each braided implant (10) is configured to provide a substantially uniform porosity within a different 0.5 mm radial diameter range. However, other different radial ranges may be used, including different vessel diameter ranges of 0.3 mm, 0.4 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, etc., depending on the needs or requirements of the system.

[0050] In some examples, a method for treating an aneurysm is disclosed. The method may include determining a vessel diameter associated with a vessel of the aneurysm; selecting one of a plurality of braided implants for treating the vessel (e.g., based on the determined vessel diameter), wherein each braided implant comprises a substantially uniform porosity over at least a 1 mm vessel diameter range, each braided implant being configured to provide a substantially uniform porosity over a different 1 mm diameter range; and treating the vessel with one of the plurality of braided implants.

[0051] In some examples, the blood vessel is tapered and includes a proximal diameter and a distal diameter that differ by at most 1 mm, wherein determining the blood vessel diameter includes comparing the proximal diameter and the distal diameter.

[0052] In some examples, the blood vessel is tapered and has a blood vessel diameter difference of about 1 mm, and the method further includes maintaining a substantially consistent porosity within the blood vessel diameter difference of about 1 mm.

[0053] In some examples, the method includes configuring each braided implant to cover a range of blood vessel diameters with a 0.5 mm overlap between each respective other braided implant.

[0054] In some examples, the vessel diameter is tapered and ranges between approximately 3 mm-4 mm.

[0055] In some examples, the vessel diameter is tapered and ranges between approximately 3.5 mm-4.5 mm.

[0056] In some examples, the vessel diameter is tapered and ranges between approximately 4 mm-5 mm.

[0057] In some examples, the vessel diameter is tapered and ranges between approximately 4.5 mm-5.5 mm.

[0058] In some examples, the vessel diameter is tapered and ranges between approximately 5.0 mm-6.0 mm.

[0059] In some examples, the vessel diameter is tapered and the plurality of braided implants are configured to treat vessel diameters in the range of 1.5 mm - 6 mm.

[0060] In some examples, determining blood vessel diameter is accomplished via X-ray, fluoroscopy, MRI, or other visualization means.

[0061] In some examples, treating the blood vessel includes advancing a braided implant to the aneurysm; and reestablishing blood flow in the blood vessel by using one of the plurality of braided implants to exclude the aneurysm and divert blood flow away from the aneurysm.

[0062] To achieve the above and related purposes, certain exemplary aspects are described herein in conjunction with the following description and accompanying drawings. However, these aspects are merely indicative of some of the various ways in which the principles of the claimed subject matter may be employed, and the claimed subject matter is intended to include all such aspects and their equivalents. Other advantages and novel features will become apparent from the following detailed description when considered in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0063] The above and other aspects of the present solution are further discussed with reference to the following detailed description and in conjunction with the accompanying drawings, in which the same reference numerals indicate the same structural elements and features in various figures. The accompanying drawings are not necessarily drawn to scale, but instead, emphasis is placed on illustrating the principles of the invention. The accompanying drawings depict one or more specific implementations of the apparatus of the present invention by way of example only and not by way of limitation.

[0064] Figure 1 is a schematic enlarged view of a portion of an implant body formed of a single strand and one or more radiopaque strands in accordance with the present invention;

[0065] Figure 2depicts a side plan view of an exemplary blood vessel contemplated for use with the braided implant of the present disclosure;

[0066] Figure 3 is a graph showing porosity versus vessel diameter for an exemplary braided implant of the present disclosure;

[0067] Figure 4 for a graph comparing porosity versus vessel diameter for an exemplary braided implant of the present disclosure relative to a conventional device;

[0068] Figure 5 is a graph showing pore density and number of wires versus vessel diameter for a set of exemplary braided implants of the present disclosure;

[0069] Figure 6 for a graph comparing porosity versus vessel diameter for a set of exemplary braided implants of the present disclosure relative to a set of conventional devices;

[0070] Figure 7 A flowchart depicting exemplary method steps summarizing the present disclosure; and

[0071] Figure 8 A flow chart summarizing exemplary method steps of the present disclosure is depicted. DETAILED DESCRIPTION

[0072] Although example embodiments of the disclosed technology are explained in detail herein, it should be understood that other embodiments may be envisioned. Therefore, it is not intended that the scope of the disclosed technology be limited to the details of the construction and arrangement of the components set forth in the following description or shown in the accompanying drawings. The disclosed technology can have other embodiments and can be practiced or implemented in various ways.

[0073] It should also be noted that, as used in this specification and the appended claims, the singular forms "a", "an", and "the" include plural referents unless the context clearly dictates otherwise. The term "comprising" or "containing" or "including" means that at least the named compound, element, particle, or method step is present in the composition or article or method, but does not exclude the presence of other compounds, materials, particles, method steps, even if such other compounds, materials, particles, method steps have the same function as those named.

[0074] In describing the example embodiments, terminology will be employed for the sake of clarity. It is intended that each term assumes its broadest meaning as understood by those skilled in the art, and includes all technical equivalents that operate in a similar manner to achieve similar purposes. It should also be understood that reference to one or more steps of a method does not exclude the presence of additional method steps or intermediate method steps between those explicitly identified steps. The steps of the method may be performed in an order different from that described herein without departing from the scope of the disclosed technology. Similarly, it should also be understood that reference to one or more components in a device or system does not exclude the presence of additional components or intermediate components between those explicitly identified components.

[0075] As discussed herein, the vasculature of a "subject" or "patient" can be the vasculature of a human or any animal. It should be understood that the animal can be of any suitable type, including, but not limited to, a mammal, a veterinary animal, a livestock animal, or a pet animal, etc. For example, the animal can be a laboratory animal (e.g., a rat, a dog, a pig, a monkey, etc.) that is specifically selected to have certain characteristics similar to humans. It should be understood that the subject can be, for example, any suitable human patient.

[0076] As discussed herein, an "operator" may include a physician, surgeon, or any other individual or delivery instrument associated with delivering a braid to the vasculature of a subject.

[0077] As discussed herein, "strand" in its broadest sense is intended to include a wire, fiber, filament, or other single elongated member.

[0078] As discussed herein, "radiopaque" is used in the normal sense of radiodense, that is, formed of one or more materials that inhibit the passage of electromagnetic radiation to increase visibility during imaging. Suitable radiopaque materials for use in accordance with the present invention include platinum, chromium, cobalt, tantalum, tungsten, gold, silver, and alloys thereof.

[0079] The braided implant 10 of the present disclosure may be better understood when viewing the accompanying drawings attached to the present disclosure. Figure 1, a schematic enlarged view of a portion of a braided implant 10 is shown according to an example of the present disclosure. The braided implant 10 may be formed by a single strand 12 and one or more radiopaque strands 14, the single strand 12 being composed of at least a first material. In this configuration, the implant 10 is woven to include at least a second strand 16. In another configuration indicated by dashed lines, the implant 10 also includes strands 18 and 20 formed by monofilaments 22 and 24, each of which is laid together with monofilaments 26 and 28, respectively. The pattern of the implant 10 woven in some configurations and braided in other configurations includes an opening 30 defined by a single strand 12 oriented in a first direction and by single strands 24 and 25 oriented in a second direction, for example, transverse to the first direction. The implant 10 also includes openings 32 and 34 defined on either side of the strands 14 by single strands 13 and 15 oriented in the same direction as the strands 14 and by single strands 24, 25 and 27 oriented in a transverse direction. In some configurations, openings 32 and 34 are slightly larger than opening 30 which is defined by only a single strand; in other configurations, all of openings 30, 32, and 34 are substantially identical.

[0080] Other embodiments of implant 10 of the present disclosure are contemplated, and these embodiments can also be observed in U.S. Patent Publication 2016 / 0058524, which is incorporated herein by reference in its entirety. In some examples, the braided implant 10 configuration of the present disclosure is considered to have a pattern substantially identical to that of an implant 10 formed of only a single strand of material. Because multiple strands are braided, woven or otherwise placed parallel to each other in the same manner, as if utilizing a single strand of radiopaque material, and especially when each filament of multiple strands has the same diameter as a single strand, there is little or no mechanical impact on implant performance such as flexibility, expansion capacity, and curling profile.

[0081] Go to Figure 2, which shows a side plan view of an exemplary blood vessel envisioned for use with the implant 10 of the present disclosure. It can be seen that the exemplary blood vessel tapers along the longitudinal axis of its internal carotid artery (ICA). See J NeuroIntervent Surg (2012) by Rai AT, Hogg JP, Cline B et al., which is incorporated herein by reference in its entirety. The Rai study undertook to determine the typical length, diameter, and taper of blood vessels in the forebrain circulation. Arterial diameters were measured at the proximal cavernous ICA, the terminal ICA, the origin of the middle cerebral artery MCA, and the origin of the M2. The length between these endpoints was calculated along the centerline. The vascular taper of the ICA was calculated as the change in caliber per unit length. In conducting this study, the Rai study determined that the average diameters of the cavernous ICA and the terminal ICA were 5mm±0.6mm and 3.6mm±0.4mm, respectively. The average ICA taper was 0.04mm±0.02mm / 1mm. For the MCA, the diameters at the origin of the MCA and M2 were measured to be 3.1 mm ± 0.4 mm and 2.4 mm ± 0.4 mm, respectively.

[0082] Figure 2 Non-limiting examples of diameter measurements taken at various lengths from the proximal cavernous ICA toward the ICA terminal end are provided to further illustrate the tapering nature of the vessel. Rai studies demonstrated that the ICA tapers from its proximal cavernous segment to the ICA terminal end that the implant 10 is configured to treat.

[0083] Go to Figure 3 , a graph is provided showing the percentage of porosity of an exemplary braided implant 10 of the present disclosure compared to the vessel diameter studied by the present disclosure. It can be seen that the braided implant 10 of the present disclosure maintains relatively consistent pore size and porosity within a 1 mm vessel diameter range. Throughout the present disclosure, when referring to a vessel diameter range, the term means a diameter range measured between two separate locations in a vessel treated by the braided implant 10. For example, a practitioner using X-ray visualization may measure the vessel diameter of the proximal corpus cavernosum ICA as 4.2 mm, while the vessel diameter toward the end of the ICA may be 3.2 mm. In this regard, the vessel diameter range in this exemplary tapered vessel will be 1 mm. The implant 10 of the present disclosure is designed to accommodate such tapered vessels within these exemplary vessel diameter ranges while also maintaining a substantially consistent target porosity. This is particularly advantageous because it means that fewer implants are needed to accommodate vessels that are more tapered than conventional devices (e.g., a vessel diameter range of approximately 0.25 mm) or that are more tortuous than is typically seen in the neurovascular system.

[0084] thus, Figure 3An exemplary blood vessel having a 1 mm vessel diameter range between 3.5 mm and 4.5 mm is depicted. In this example, the braided implant 10 of the present disclosure maintains a porosity of approximately 70%. Specifically, at a diameter of 3.5 mm, the porosity of the braid is approximately 69%. At a diameter of 4.0 mm, the porosity of the braid is approximately 69%. At a diameter of 4.5 mm, the porosity of the braid is approximately 67%.

[0085] Go to Figure 4 , provides a graph summarizing the comparisons made, showing the exemplary implant 10 of the present disclosure relative to the Medtronic Pipeline within a 1 mm vessel diameter range. TM Porosity of a PED device (PED) versus vessel diameter. Specifically, the braided implant 10 and the PED device were compared between vessel diameters ranging from 3.5 mm to 4.5 mm. It can be seen that the braided implant 10 of the present disclosure is superior to the previous Figure 3 , and the PED device 10 maintains a relatively consistent pore size and porosity of about 70% within the 1 mm diameter range in the same range shown in . In contrast, the PED device exhibits a porosity of 80% at a 3.5 mm vessel diameter, a porosity of 70% at a 4 mm vessel diameter, and a porosity of less than 50% at a 4.5 mm vessel diameter. In other words, as the diameter of the vessel increases within the 1 mm range, the porosity of the PED device decreases significantly, while the exemplary braided implant 10 of the present disclosure exhibits a substantially consistent porosity within the 1 mm diameter range.

[0086] Figure 4 The porosity of each device as it expands is also shown and features the same. In some examples, the braided implant 10 is designed so that the indicated vessel diameter coincides with the peak of the porosity curve and the plateau region around it (which has very little deviation from the target porosity). For example, in Figure 3 , the braided implant 10 is shown for artery diameters ranging from 3.5 mm to 4.5 mm. The device maintains very close to the target porosity of 70% throughout its expansion range with a width of 1.0 mm.

[0087] For example, when the device is compressed, it is dense and therefore has very low porosity (see e.g. Figure 3 As the device expands, the porosity increases as the pores of the braided implant 10 open. At a certain point, the porosity reaches a peak, when the braid angle is 90 degrees, because each pore can be square and as large as possible, such as Figure 3Further expansion of the diameter beyond this peak value then reduces the size of each pore and thus the porosity. When the braided implant 10 reaches a maximum diameter at its expansion limit, the braided implant 10 is again very dense and the porosity is correspondingly low (see, e.g. Figure 3 ).

[0088] In contrast, other known devices may be designed differently so that the plateau region of the porosity curve is not as wide as 1.0 mm, or they may represent arterial diameters that are inconsistent with the plateau region. In these older approaches, the range of diameters consistent with the target porosity will be narrow because, outside the plateau, small changes in arterial diameter result in large deviations from the target porosity. Thus, other known devices will not be able to treat a wide range of vessel diameters.

[0089] Go to Figure 5 , provides a graph summarizing the porosity versus vessel diameter of an exemplary braided implant 10 of the present disclosure. Specifically, Figure 5 Six separate braided implants (10) are shown, each having a vessel diameter range of approximately 1 mm and offset from each other by approximately half of that range (0.5 mm). The legend shows the vessel diameter range from minimum to maximum and the corresponding label of the applicable braided implant (10). For example, the first braided implant (10) is configured for a vessel diameter range between 2.0 mm and 3.0 mm and has a label of 2.5 mm. The first braided implant (10) has 48 wires with a hole density (mm 2 ) is 18. The second braided implant (10) is configured for a vessel diameter range between 2.5 mm and 3.5 mm, and its label is 3 mm. The second braided implant (10) has 64 wires, and its hole density (mm 2 ) is 23. The third braided implant (10) is configured for a range of vessel diameters between 3.0 mm and 4.0 mm, and its label is 3.5 mm. The third braided implant (10) has 64 wires, and its hole density (mm 2 ) is 18. The fourth braided implant (10) is configured for a vessel diameter range between 3.5 mm and 4.5 mm, and its label is 4.0 mm. The fourth braided implant (10) has 72 wires, and its hole density (mm 2 ) is 19. The fifth braided implant (10) is configured for a vessel diameter range between 4.0 mm and 5.0 mm, and its label is 4.5 mm. The fifth braided implant (10) has 96 wires, and its hole density (mm 2) is 21. The sixth braided implant (10) is configured for a range of vessel diameters between 4.5 mm and 5.5 mm, and its label is 5 mm. The sixth braided implant (10) has 96 wires, and its hole density (mm 2 ) is 21.

[0090] Go to Figure 6 , a graph summarizing the comparisons made is provided, showing porosity versus vessel diameter for a set of exemplary implants (10) of the present disclosure relative to a set of PED devices over different vessel diameter ranges, including from 2 mm to 6 mm. Specifically, in a first braided implant 10 indicated as being configured for a 2 mm to 3 mm vessel diameter range, it was observed that the braided implant 10 provided approximately 70% porosity, while a similar PED device was only able to maintain approximately 70% porosity over a vessel diameter range of 2.5 mm to 2.75 mm (i.e., only a 0.25 mm vessel diameter range). As shown, for the PED device, another PED device within the relevant diameter range is only required to complete the clearance from a 2.75 mm to 3.0 mm vessel diameter range. The first braided implant (10) is constructed of 48 strands, and the PED device is similarly constructed of 48 strands. For the 2.0 mm to 2.5 mm range, two additional PED devices are required because the PED device only exhibits a 0.25 mm range in which 70% porosity can be maintained during use.

[0091] Figure 6 Also depicted is a second braided implant (10) indicated as being configured for a vessel diameter range of 2.5 mm to 3.5 mm, and it is observed that the braided implant (10) provides a porosity of approximately 70%, while a similar PED device is only able to maintain a porosity of approximately 70% within a vessel diameter range of 3.0 mm to 3.25 mm (i.e., only a 0.25 mm vessel diameter range). The second braided implant (10) in this example is composed of 64 strands of wire, while the PED device is composed of 48 strands of wire. In other words, in the case of a vessel diameter of 3 mm, the second braided implant (10) uses approximately 21.3 strands / mm of vessel diameter, while the PED device uses 16 strands / mm of vessel diameter. Due to the use of fewer strands per diameter, the porosity versus diameter curve of the PED device has a narrower platform portion than the second braided implant (10). In addition, for the PED device, another PED device within the relevant diameter range only needs to complete the gap from the vessel diameter range of 3.25 mm to 3.50 mm. Additionally, two additional PED devices are required relative to the 2.5 mm to 3.0 mm range and the first braided implant (10) because the PED device only exhibits a 0.25 mm range that is able to maintain 70% porosity during use.

[0092] Figure 6 Also depicted is a third braided implant (10) indicated as being configured for a vessel diameter range of 3.0 mm to 4.0 mm, and it is observed that the braided implant (10) provides a porosity of approximately 70%, while a similar PED device is only able to maintain a porosity of approximately 70% within a vessel diameter range of 3.5 mm to 3.75 mm (i.e., only a 0.25 mm vessel diameter range). The third braided implant (10) in this example is composed of 64 strands of wire, while the PED device is composed of 48 strands of wire. In other words, in the case of a vessel diameter of 3.5 mm, the third braided implant (10) uses approximately 18.3 strands / mm of vessel diameter, while the PED device uses 13.7 strands / mm of vessel diameter. Due to the use of fewer strands per diameter, the porosity versus diameter curve of the PED device has a narrower platform portion than the third braided implant (10). In addition, for the PED device, another PED device within the relevant diameter range only needs to complete the gap from the vessel diameter range of 3.75 mm to 4.00 mm.

[0093] Figure 6 Also depicted is a fourth braided implant (10) indicated as being configured for a vessel diameter range of 3.5 mm to 4.5 mm, and it is observed that the braided implant (10) provides a porosity of approximately 70%, while a similar PED device is only able to maintain a porosity of approximately 70% within a vessel diameter range of 4.0 mm to 4.25 mm (i.e., only a 0.25 mm vessel diameter range). The fourth braided implant (10) in this example is composed of 72 strands of wire, while the PED device is composed of 48 strands of wire. In other words, in the case of a vessel diameter of 4 mm, the fourth braided implant (10) uses approximately 18 strands / mm of vessel diameter, while the PED device uses 12 strands / mm of vessel diameter. Due to the use of fewer strands per diameter, the porosity versus diameter curve of the PED device has a narrower platform portion than the fourth braided implant (10). In addition, for the PED device, another PED device within the relevant diameter range only needs to complete the gap from the vessel diameter range of 4.25 mm to 4.50 mm.

[0094] Figure 6Also depicted is a fifth braided implant (10) indicated as being configured for a 4.0 mm to 5.0 mm vessel diameter range, and it is observed that the braided implant (10) provides a porosity of approximately 70%, while a similar PED device is only able to maintain a porosity of approximately 70% within a vessel diameter range of 4.5 mm to 4.75 mm (i.e., only a 0.25 mm vessel diameter range). The fifth braided implant (10) in this example is composed of 96 strands of wire, while the PED device is composed of 48 strands of wire. In other words, in the case of a vessel diameter of 4.5 mm, the fifth braided implant (10) uses approximately 21.3 strands / mm of vessel diameter, while the PED device uses 10.7 strands / mm of vessel diameter. Due to the use of fewer strands per diameter, the porosity versus diameter curve of the PED device has a narrower platform portion than the fifth braided implant (10). In addition, for the PED device, another PED device within the relevant diameter range only needs to complete the gap from the 4.75 mm to 5.00 mm vessel diameter range.

[0095] Figure 6 Also depicted is a sixth braided implant (10) indicated as being configured for a vessel diameter range of 4.5 mm to 5.5 mm, and it is observed that the braided implant (10) provides a porosity of approximately 70%, while a similar PED device is only able to maintain a porosity of approximately 70% within a vessel diameter range of 5.0 mm to 5.25 mm (i.e., only a 0.25 mm vessel diameter range). The sixth braided implant (10) in this example is composed of 96 strands of wire, while the PED device is composed of 48 strands of wire. In other words, in the case of a vessel diameter of 5.0 mm, the sixth braided implant (10) uses approximately 19.2 strands / mm of vessel diameter, while the PED device uses 9.6 strands / mm of vessel diameter. Due to the use of fewer strands per diameter, the porosity versus diameter curve of the PED device has a narrower platform portion than the sixth braided implant (10). In addition, for the PED device, another PED device within the relevant diameter range only needs to complete the gap from the vessel diameter range of 5.25 mm to 5.50 mm.

[0096] like Figure 6 As seen in FIG. 1 , for each indicated 1 mm vessel extent covered by one of the braided implants (10), the practitioner would need four separate PED devices for similar coverage in the corresponding vessels, which is inconvenient, wasteful, and potentially unsafe due to the nature of the bleeding events and significant tapering of the vessels. For example, if the vessel tapers more than 0.25 mm, no current PED device is able to adequately treat the diseased vessel in a manner that maintains a substantially consistent target porosity of 70%.

[0097] exist Figure 7, a flowchart depicts an exemplary method 700 and corresponding steps. Step 710 includes determining a vessel diameter associated with a vessel having an aneurysm. Step 720 includes selecting one of a plurality of braided implants (10) for treating the vessel, wherein each braided implant (10) includes a substantially uniform porosity within a vessel diameter range of up to 1 mm, and each braided implant (10) is configured to provide a substantially uniform porosity within different 1 mm diameter ranges. Step 730 includes treating the vessel with one of the plurality of braided implants (10).

[0098] exist Figure 8 , a flowchart depicts an exemplary method 800 and corresponding steps. Step 810 includes determining a vessel diameter associated with a vessel containing an aneurysm. Step 820 includes selecting one of a plurality of braided implants (10) for treating the vessel, wherein each braided implant (10) includes a substantially uniform porosity within at least a 0.5 mm vessel diameter range, and each braided implant (10) is configured to provide a substantially uniform porosity within different 0.5 mm diameter ranges. Step 830 includes treating the vessel with one of the plurality of braided implants (10).

[0099] The braided implant (10) of the present disclosure is particularly advantageous because physicians can benefit from a wider indicated diameter range because it can provide some tolerance for measurement inaccuracies and / or errors (e.g., an artery measured as 3.3 mm on an x-ray or any other visualization device when it is actually 3.5 mm). Physicians can also benefit because a wider indicated diameter range can maintain a consistent porosity close to the target porosity, which is common. The implant (10) of the present disclosure is also advantageous because the anatomical range of arterial diameters can be handled with fewer devices, simplifying the device selection process and saving storage space for the inventory they must keep on hand.

[0100] In certain examples, a set or family of implants (10) is disclosed, each implant (10) having a 1.0 mm wide range of indicated diameters, arranged such that they cover an anatomical range with 0.5 mm overlap, such as Figure 5 and Figure 6As shown. It should be noted that the entire depicted and described range is for a range of vessel diameters of up to 1 mm for the corresponding braided implant (10). However, it is contemplated that the braided implant (10) may be adapted for a range of vessel diameters greater than 1 mm. The braided implant (10) of the present disclosure is particularly advantageous because, for any given arterial diameter, there are two different options of devices that can be selected. For example, an artery with a diameter of 3.25 mm may be at a desired treatment location in the vasculature. If the artery gradually decreases (i.e., becomes smaller) as you move away from the treatment location, then the physician may select a smaller implant from a group or family of implants by, for example, selecting an implant listed at 2.5 mm instead of 3.5 mm. In this regard, the arterial segment is exposed to the target porosity over a longer length. Conversely, if the artery gradually increases (i.e., becomes larger) as you move away from the treatment location, then the physician may select a larger implant from a group or family of implants by, for example, selecting an implant listed at 3.0 mm to 4.0 mm. In this regard, similar to the previous example, the arterial segment is exposed to the target porosity over a longer length.

[0101] An advantage of the present disclosure is that a braided implant having a wide platform region with a characteristic porosity curve is provided such that the implant or a family or group of implants can address arterial diameters within a platform of an indicated range of approximately 1.0 mm wide, and overlap the indicated diameter ranges so that the physician can select the best option based on the anatomy presented.

[0102] In some examples, each side-by-side filament of the braided implant of the present disclosure comprises a monofilament of radiopaque material. In one configuration, the carrier having multiple strands is substantially the same as the carrier for the single strand. Each of the multiple side-by-side filaments is a monofilament of radiopaque material. Preferably, the diameter of each side-by-side filament is substantially the same as the diameter of the single strand. Forming the body comprises establishing a first spacing pattern such as an open braid pattern or an open braid pattern, and a first wall thickness, and each multiple strand is joined in the first spacing pattern without substantially deviating from the pattern and without substantially changing the first wall thickness.

[0103] In some techniques, at least one multi-strand carrier is used for every dozen single-strand carriers. Some machines have at least 42 carriers, such as 48 carriers, and at least 6 of the carriers, such as 8 carriers, are loaded with multiple strands of radiopaque material. This still results in a 48-carrier braid, but with double the number of radiopaque strands when the 8 carriers are loaded with single strands of radiopaque material.

[0104] The braided implants (including flow redirectors) of the present disclosure can be designed for a specific percentage of coverage area per arterial region after they have been delivered and expanded in place at the treatment site, or conversely, the percentage of open area remaining per arterial region, referred to in the present disclosure as "porosity". The designed porosity can be adjusted by braiding parameters, such as the number of wires, the width of the wires, the braid diameter, and the braid angle, which can be measured alternatively as PPI or pitch. Once the target porosity is identified based on these factors, the braid design can be adjusted to achieve the target porosity when expanded to the indicated arterial diameter.

[0105] The braided implants of the present disclosure (including flow diverters) can have many variations within a group or family that achieve a target porosity with varying arterial diameters. Thus, the group or family of devices together allow physicians to treat any diameter artery within the anatomical range (1.5 mm to 6 mm is typical for neurovascular).

[0106] The descriptions contained herein are examples illustrating various embodiments and are not intended to limit the scope of the present disclosure. As described herein, the present invention contemplates many variations and modifications of usable systems, devices, or methods. Variations may include, but are not limited to, alternative geometries of elements and components described herein, thereby utilizing any of the many materials of each component or element (e.g., radiopaque materials, memory shape metals, etc.). These modifications will be apparent to those of ordinary skill in the art and are intended to be within the scope of the following claims.

[0107] The specific configuration, the choice of materials, and the size and shape of the various elements can be changed according to the specific design specifications or constraints of the system or method constructed according to the principles of the disclosed technology as needed. These changes are intended to be included in the scope of the disclosed technology. Therefore, the embodiments disclosed by the present invention are considered to be illustrative and not restrictive in all aspects. Therefore, it is apparent from the foregoing that, although specific forms of the present disclosure have been shown and described, various modifications may be made without departing from the spirit and scope of the present invention, and all changes within the meaning and scope of its equivalents are intended to be included therein.

Claims

1. A braided implant configured as a flow diverter for treating an aneurysm, the implant comprising: a woven mesh configured to maintain a substantially consistent target porosity in a tapered blood vessel having a range of blood vessel diameters up to 1 mm; wherein the braided mesh is configured to maintain the substantially uniform target porosity while in the tapered blood vessel between a proximal end and a distal end of the braided mesh; and Wherein the braided implant further comprises an indicated vessel diameter, and wherein the braided implant is configured such that the indicated vessel diameter coincides with a peak of a porosity curve of the braided implant showing porosity versus vessel diameter.

2. An implant according to claim 1, wherein the tapered blood vessel comprises a proximal diameter and a distal diameter, wherein the proximal diameter and the distal diameter differ by at most 1 mm, wherein the blood vessel diameter range of at most 1 mm is defined by comparing the proximal diameter and the distal diameter.

3. The implant of claim 1, wherein the substantially uniform target porosity is approximately 70%.

4. The implant of claim 1, wherein the predetermined length between the proximal and distal ends of the braided mesh in the tapered blood vessel is at least 3 cm.

5. The implant of claim 1, wherein the predetermined length between the proximal and distal ends of the braided mesh in the tapered blood vessel is at least 1 cm.

6. The implant of claim 1, wherein the braided implant further comprises a porosity plateau corresponding to a 1 mm radial range on a vessel diameter disposed about the peak of the porosity curve.

7. The implant of claim 1, wherein the braided implant further comprises a porosity plateau that coincides with a 1 mm radial range on a vessel diameter disposed about the peak of the porosity curve.

8. The implant of claim 1, wherein the pore density of the braided implant is 18 pores / mm 2 Up to 23 holes / mm 2 .

9. The implant of claim 1, wherein the braided implant is a substantially cylindrical porous structure.

10. The implant of claim 1, wherein the braided implant is formed from a plurality of individual strands and one or more radiopaque strands, the plurality of individual strands being composed of at least a first material.

11. The implant according to claim 1, wherein the braided implant is formed of a plurality of strands formed of monofilaments, each of the plurality of strands being laid separately with the monofilaments.

12. A system for treating an aneurysm, the system comprising: a plurality of braided implants, wherein each braided implant comprises a substantially uniform porosity within a different 1 mm radial range over a vessel diameter, each braided implant being configured to provide a substantially uniform porosity within a different 1 mm radial diameter range; Wherein the braided implant further comprises an indicated vessel diameter, and wherein the braided implant is configured such that the indicated vessel diameter coincides with a peak of a porosity curve of the braided implant showing porosity versus vessel diameter.

13. A system according to claim 12, wherein the braided implant is configured for use in a tapered blood vessel, wherein the tapered blood vessel includes a proximal diameter and a distal diameter that differ by at most 1 mm, wherein the different 1 mm radial range in blood vessel diameter is defined by comparing the proximal diameter and the distal diameter.

14. The system of claim 12, wherein the plurality of braided implants comprises: a first braided implant configured to treat a blood vessel diameter ranging from 2 mm to 3 mm; a second braided implant configured to treat a blood vessel diameter ranging from 2.5 mm to 3.5 mm; a third braided implant configured to treat a blood vessel diameter ranging from 3.0 mm to 4.0 mm; a fourth braided implant configured to treat a blood vessel diameter range of 3.5 mm to 4.5 mm; a fifth braided implant configured to treat a blood vessel diameter ranging from 4.0 mm to 5.0 mm; and a sixth braided implant configured to treat a blood vessel diameter range of 4.5 mm to 5.5 mm; Wherein said porosity of each braided implant is between 65% and 70%.

15. The system of claim 14, wherein each braided implant comprises at least 18 holes / mm 2 Up to 23 holes / mm 2 range of pore density.

16. The system of claim 12, wherein each of the plurality of braided implants is offset from one another by approximately half of the radial extent of a next smallest braided implant of the plurality of braided implants over a vessel diameter.